menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee

16 1
17.06.2025
"I’m sure someone’s lost their job," said the CEO of Sandoz, which has now filed to launch a generic GLP-1 in Canada next year.

© Fortune